Arakis Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 38

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $131M

Arakis General Information

Description

Developer of medicinal products. The company discovers, develops and commercializes medicinal products based on established drugs and drug templates. Its chosen therapeutic areas are inflammatory disease and pain.

Contact Information

Website
www.arakis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Chesterford Research Park
  • Little Chesterford
  • Saffron Walden CB10 1XL
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Chesterford Research Park
  • Little Chesterford
  • Saffron Walden CB10 1XL
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arakis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Aug-2005 $131M Completed Generating Revenue
3. Later Stage VC (Series C) 06-Sep-2004 Completed Startup
2. Early Stage VC (Series B) 29-Apr-2002 $14.2M $18.5M Completed Startup
1. Early Stage VC 01-Jan-2000 $4.32M $4.32M Completed Startup
To view Arakis’s complete valuation and funding history, request access »

Arakis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arakis Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
3i Group PE/Buyout Minority
Alice Ventures Venture Capital Minority
Close Finsbury Eurotech Venture Capital Minority
Excalibur Group Holdings Corporation Minority
Finsbury Life Sciences Investment Trust Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Arakis Acquisitions (1)

Arakis’s most recent deal was a Merger/Acquisition with Sirus. The deal was made on 01-Mar-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sirus 01-Mar-2004 Merger/Acquisition Biotechnology
To view Arakis’s complete acquisitions history, request access »

Arakis FAQs

  • When was Arakis founded?

    Arakis was founded in 2000.

  • Where is Arakis headquartered?

    Arakis is headquartered in Saffron Walden, United Kingdom.

  • What is the size of Arakis?

    Arakis has 38 total employees.

  • What industry is Arakis in?

    Arakis’s primary industry is Drug Discovery.

  • Is Arakis a private or public company?

    Arakis is a Private company.

  • What is the current valuation of Arakis?

    The current valuation of Arakis is .

  • What is Arakis’s current revenue?

    The current revenue for Arakis is .

  • How much funding has Arakis raised over time?

    Arakis has raised $53.9M.

  • Who are Arakis’s investors?

    3i Group, Alice Ventures, Close Finsbury Eurotech, Excalibur Group Holdings, and Finsbury Life Sciences Investment Trust are 5 of 13 investors who have invested in Arakis.

  • When was Arakis acquired?

    Arakis was acquired on 31-Aug-2005.

  • Who acquired Arakis?

    Arakis was acquired by Nxera Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process